TCL Archive FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint. July 21, 2006
TCL Archive In Brief: NCI Awards 4 Contracts For Enrichment Program; Dana-Farber Names Breast Center Leadership July 10, 1992
TCL Archive Commerce Dept. Socks NCI For Cancergram Paid Subscriptions; NCAB Committee Oks OD Requests October 22, 1982
TCL Archive NCI Needs $107 Million More In FY 1982 Than Asked for Key Programs, R01s And P01s, New Initiatives April 17, 1981
